News
U.S. President Donald Trump signed an executive order this week to lower the cost of prescription drugs in the United States by requiring drug companies to match the lower prices found in other countr ...
Pfizer has said it will shed staff and cut its operating costs by around $ ... It has not provided any indication of the number of job losses. Around $4.2 billion of the correction will result ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
However, since that period, this valuation has once again declined and there have been announcements ... This has seen Pfizer announce repeated job cuts from its US operations since the beginning ...
Kennedy Jr. Pfizer leans on cost cuts to offset falling revenue Pfizer ... said amid fears President Donald Trump's April 2 tariffs announcement could include products made in Europe.
1d
Barchart on MSNStock Index Futures Slip Ahead of Fed Speak, Home Depot Earnings on TapReal-time index price for TSX American Preferred Stock Index (STNC), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Pfizer will continue operating in Lee County after consolidating facilities. The move comes 18 months after Pfizer confirmed ...
U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...
As with many other companies Pfizer Inc. (NYSE:PFE) makes use of debt. But the real question is whether this debt is making the company risky. Debt and other liabilities become risky for a ...
My monthly update and commentary on the top dividend stock picks from the Barron's Better Bets list, May 2025 edition. Read ...
Tourmaline Bio disclosed results for a potential rival to a Novo Nordisk drug. Elsewhere, data emerged for a psychedelic and CRISPR Therapeutics expanded its toolkit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results